The Rutgers-Cleveland Clinic Consortium is part of the Armed Forces Institute of Regenerative Medicine (AFIRM), a multi-institutional, interdisciplinary network working to develop advanced treatment options for our severely wounded servicemen and women. The AFIRM is managed and funded through the US Army Medical Research and Materiel Command (MRMC); with additional funding from the US Navy, Office of Naval Research; the US Air Force, Office of the Surgeon General; the National Institutes of Health; the Veterans Administration; and local public and private matching funding.
AFIRM’s mission is to develop new products and therapies to treat severe injuries suffered by US service members in the current wars. The AFIRM teams, working in research laboratories and clinics across the country, are advancing biological therapies (including adult stem cells and growth factors), tissue and biomaterials engineering, and advanced transplantation methods. These new treatments will enable the body to repair, replace, restore and regenerate damaged tissues and organs.
"Bioactive Scaffolds - from the Nano to the Macro Scale"
General Gilman visited Rutgers Cleveland Clinic Consortium
On September 13th, 2010 the Rutgers Cleveland Clinic Consortium hosted General Gilman, Commanding General of the USAMRMC. The General gave closing remarks that energized and reinvigorated RCCC project leaders, investigators and staff.
Photography by Don Lindorfer
Annual Skin Workshop Highlighted AFIRM Technologies
October 12th-13th, 2011 4th Annual Skin Workshop
“Skin reconstruction for wounds, burns and deep skin trauma”
Endorsed by the Rutgers Cleveland Clinic Consortium of Armed Forces Institute for Regenerative Medicine - AFIRM.
